Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy. (Q40964242)
Jump to navigation
Jump to search
scientific article published on March 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy. |
scientific article published on March 1999 |
Statements
Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy (English)
Won J
Kim H
Park EJ
Hong Y
Kim SJ